Author

Abdulaziz Siyal

King Saud Medical City

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:whole-exome sequencing· 2 Assay:DNA methylation· 1

Frequent Co-Authors

Amer MahmoodiD· 2 shared Masood A. ShammasiD· 2 shared Nawaf AlanaziiD· 2 shared Sarah AlMukhaylidiD· 2 shared Zafar IqbaliD· 2 shared Aamer AleemiD· 1 shared Muhammad M. AbsariD· 1 shared SALMAN ABDUL BASIT· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Amer MahmoodORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A retrospective case-control study for Clinical Validation of mutated ZNF208 as a novel biomarker of fatal blast crisis in Chronic Myeloid Leukemia

Nawaf Alanazi, Abdulaziz Siyal, SALMAN ABDUL BASIT, Masood A. Shammas, Aamer Aleem, Amer Mahmood, Sarah AlMukhaylid, Zafar Iqbal

This study validates ZNF208 mutation (c.64G>A) as a specific biomarker for advanced phase CML through targeted resequencing in a case-control cohort.

medRxiv · Mar 9, 2024 · PreprintGenetic & Genomic Medicine

Utilization of targeted resequencing for clinical validation of mutated FANCD2 gene as a promising molecular biomarker of early disease progression in Chronic Myeloid Leukemia

Nawaf Alanazi, Abdulaziz Siyal, Muhammad M. Absar, Masood A. Shammas, Sarah AlMukhaylid, Amer Mahmood, Zafar Iqbal

This study identifies a FANCD2 mutation as a specific biomarker for early progression in Chronic Myeloid Leukemia using targeted resequencing and NGS analysis.

medRxiv · Dec 19, 2023 · PreprintGenetic & Genomic Medicine